Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -2.76 is 539% below its 5-year average of -0.43, near the low end of its 5-year range (-3.09–1.49).
28.07% below its 12-month average of -2.15.
Reported quarterly EPS; no daily interpolation. Q3 FY2026 (2026-06-30): 0.05.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T13:30:40.557Z. Historical observations retain their original dates. Historical series through 2022-05-16.
EARNINGS PER SHARE (EPS)
-2.76
EARNINGS PER SHARE (EPS) AVG TTM
-2.15
EARNINGS PER SHARE (EPS) AVG 3Y
-1.51
EARNINGS PER SHARE (EPS) AVG 5Y
-0.43
EARNINGS PER SHARE (EPS) AVG 10Y
-0.05
EARNINGS PER SHARE (EPS) AVG 15Y
0.63
EARNINGS PER SHARE (EPS) AVG 20Y
0.33
CURRENT VS TTM AVG
-28.07%
CURRENT VS 3Y AVG
-82.78%
CURRENT VS 5Y AVG
-538.89%
CURRENT VS 10Y AVG
-5814.29%
CURRENT VS 15Y AVG
-539.38%
CURRENT VS 20Y AVG
-946.61%
Azenta, Inc.
Market Cap
$2.01B
Earnings Per Share (EPS)
-2.76
TTM Avg
-2.15
3Y Avg
-1.51
5Y Avg
-0.43
Market Cap
$2.09B
Earnings Per Share (EPS)
-0.93
TTM Avg
-7.24
3Y Avg
-4.12
5Y Avg
-3.06
Market Cap
$2.00B
Earnings Per Share (EPS)
-0.68
TTM Avg
-0.29
3Y Avg
-0.44
5Y Avg
-0.50
Market Cap
$2.04B
Earnings Per Share (EPS)
-2.54
TTM Avg
-3.71
3Y Avg
-3.97
5Y Avg
-3.29
Market Cap
$2.03B
Earnings Per Share (EPS)
2.29
TTM Avg
1.09
3Y Avg
0.22
5Y Avg
-0.23
Market Cap
$1.99B
Earnings Per Share (EPS)
-0.80
TTM Avg
-0.89
3Y Avg
-1.03
5Y Avg
-0.96
Market Cap
$2.06B
Earnings Per Share (EPS)
4.62
TTM Avg
3.38
3Y Avg
1.11
5Y Avg
0.12
Market Cap
$1.97B
Earnings Per Share (EPS)
-1.31
TTM Avg
-2.36
3Y Avg
-2.72
5Y Avg
-2.37
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Azenta, Inc. (AZTA) | $2.01B | -2.76 | -2.15 | -1.51 | -0.43 |
| Fortrea Holdings Inc. (FTRE)vs › | $2.09B | -0.93 | -7.24 | -4.12 | -3.06 |
| AxoGen, Inc. (AXGN)vs › | $2.00B | -0.68 | -0.29 | -0.44 | -0.50 |
| Immunome, Inc. (IMNM)vs › | $2.04B | -2.54 | -3.71 | -3.97 | -3.29 |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.03B | 2.29 | 1.09 | 0.22 | -0.23 |
| Absci Corporation (ABSI)vs › | $1.99B | -0.80 | -0.89 | -1.03 | -0.96 |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.06B | 4.62 | 3.38 | 1.11 | 0.12 |
| Alvotech (ALVO)vs › | $2.05B | -0.63 | -0.39 | -1.45 | -2.42 |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.97B | -1.31 | -2.36 | -2.72 | -2.37 |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.07B | -1.50 | 0.42 | -0.42 | -0.63 |
Trailing EPS (TTM)
$-2.76
Forward EPS (Est.)
$0.50
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-09-30 | -1.22 |
| 2024-09-30 | -3.09 |
| 2023-09-30 | -0.22 |
| 2021-09-30 | 1.49 |
| 2020-09-30 | 0.88 |
| 2018-09-30 | 1.65 |
| 2017-09-30 | 0.90 |
| 2016-09-30 | -1.02 |
| 2015-09-30 | 0.21 |
| 2014-09-30 | 0.47 |
| 2013-09-30 | -0.03 |
| 2012-09-30 | 2.10 |
| 2011-09-30 | 2.02 |
| 2010-09-30 | 0.94 |
| 2009-09-30 | -3.62 |
| 2008-09-30 | -3.66 |
| 2006-09-30 | 0.36 |
| 2005-09-30 | -0.22 |
| 2003-09-30 | -5.05 |
| 2002-09-30 | -27.90 |
| 2001-09-30 | -1.65 |
| 2000-09-30 | 0.96 |
| 1999-09-30 | -0.71 |
| 1998-09-30 | -1.78 |
| 1997-09-30 | -0.66 |
| 1996-09-30 | 1.06 |
(FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown Quote observation: 2026-10-06T13:30:40.557Z. Historical observations retain their original dates. Historical series through 2021-11-24.
